Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

COVAX

A shipment of Covid-19 vaccines delivered as part of the World Health Organization-led COVAX initiative is unloaded at Felix Houphouet Boigny Airport in Abidjan, Ivory Coast on February 26, 2021. (Photo: Sia Kambou/AFP via Getty Images)

Biden Plan to Donate 500 Million Covid-19 Vaccine Doses Called 'Drop in the Bucket' in Face of Acute Global Need

"Billions of people awaiting a path out of the pandemic desperately need President Biden and other world leaders to find far greater ambition."

Brett Wilkins

While welcoming reports that U.S. President Joe Biden will commit to donating 500 million doses of the Pfizer-BioNTech Covid-19 vaccine to more than 100 countries over the coming year, activists and advocacy groups on Wednesday stressed that what the world truly needs is an urgent and ambitious plan to manufacture and distribute billions more doses of the life-saving inoculations.

Responding to reports in the New York Times, Washington Post, and other outlets that Biden plans to donate 200 million doses of the two-shot Pfizer vaccine this year and 300 million more units in 2022 via the World Health Organization-led COVAX initiative, groups including Doctors Without Borders (MSF), Public Citizen, and Oxfam urged the U.S. and other nations to go even further in the face of severe vaccine shortages in much of the Global South.

Peter Maybarduk, director of Public Citizen's Access to Medicines program, tweeted that next year is "a long time to wait for far too few doses."

"The world needs urgent new manufacturing to produce billions more doses within a year, not just commitments to buy the planned inadequate supply," Maybarduk said in a separate statement.

"We welcome this step from President Biden," he continued. "However, we have yet to see a plan from the U.S. government or the G7 of the needed ambition or urgency to make billions more doses and end the pandemic."

Niko Lusiani, Oxfam America's vaccine lead, said in a statement that "it's encouraging to see that in its quest to get America vaccinated, the Biden administration has not lost sight of the needs of those outside our borders."

"However, charity is not going win the war against the coronavirus," Lusiani asserted. "Surely, these 500 million vaccine doses are welcome as they will help more than 250 million people, but that's still a drop in the bucket compared to the need across the world."

Lusiani continued:

It's time to let the world help itself. Rather than more lucrative transactions with very profitable pharmaceutical corporations, we need a transformation toward more distributed vaccine manufacturing so that qualified producers worldwide can produce billions more low-cost doses on their own terms, without intellectual property constraints.

Ahead of the G7 Summit, Oxfam called on President Biden to rally other G7 leaders around temporarily waiving restrictive intellectual property rules, mandating companies share their technology with the World Health Organization, and investing in global, distributed manufacturing to ensure that everyone, everywhere will have access to a Covid vaccine.

In the face of international pressure, Biden surprised many observers last month when he announced his support for waiving patent protections for Covid-19 vaccines and treatments. The president's endorsement of a Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver at the World Trade Organization (WTO)—originally proffered by India and South Africa—prompted other nations to reconsider their opposition to the proposal.

"At the current rate of vaccinations, it would take low-income countries 57 years to reach the same level of protection as those in G7 countries." —Niko Lusiani, Oxfam America

Last month, China said it would support a TRIPS waiver "that is conducive to fair access to vaccines in developing countries." On Wednesday, Oxfam France executive director Cécile Duflot said French President Emmanuel Macron is now committed to supporting waiving vaccine patents. Also on Wednesday, the WTO announced during its TRIPS Council meeting that member nations would begin formal text-based negotiations on a temporary waiver of coronavirus-related patents next week.

However, nations including Germany, Japan, South Korea, Switzerland, and the United Kingdom remain opposed to a TRIPS waiver, as does the European Union. The pharmaceutical industry is also working to thwart the waiver.

Looking forward to the U.K.-led G7 leaders' summit set to begin on Friday, United Nations human rights experts on Wednesday called on leaders of the world's leading economies to ensure people in developing countries get equal access to Covid-19 vaccines and treatments.

"Billions of people in the Global South are being left behind. They see vaccines as a mirage or a privilege for the developed world," the experts said. "This situation will unnecessarily prolong the crisis, drastically increase the death toll, and deepen economic distress, possibly sowing the seeds of social unrest."

"It is shocking that, according to WHO reports, less than 1% of all vaccines administered so far have gone to low-income countries," they added.

Noting that "at the current rate of vaccinations, it would take low-income countries 57 years to reach the same level of protection as those in G7 countries," Oxfam's Lusiani said "that's not only morally wrong, it's self-defeating given the risk posed by coronavirus mutations."

As Covid-19 continues to exact a heavy toll in countries including India and Brazil, health advocates underscored the need for immediate action.

"Billions of people awaiting a path out of the pandemic desperately need President Biden and other world leaders to find far greater ambition," stressed Public Citizen's Maybarduk.


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

... We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

AOC Laments How Accused Predator Kavanaugh Ready to Rule on 'Whether to Legalize Forced Birth in the US'

The congresswoman suggested Justice Brett Kavanaugh should recuse himself from Dobbs v. Jackson Women's Health Organization, considering multiple sexual assault allegations against him that the FBI failed to investigate.

Julia Conley ·


Biden Rebuked for Plan to Implement 'Even Worse' Version of Trump's 'Remain in Mexico' Policy

"The Biden administration must stop hiding behind a flawed court order to justify" the abuse of asylum seekers, said one immigrant rights advocate.

Kenny Stancil ·


Progressive Coalition to Schumer: No More Cuts to Popular Build Back Better Bill

"Now is the moment to do everything in your power to ensure that we get the best, most inclusive, reconciliation bill possible across the finish line."

Jessica Corbett ·


New Report Urges Biden to Stop Arms Sales Fueling Saudi 'Devastation' of Yemen

"It's time for the Biden administration to cut off this support as a way to change Saudi conduct and relieve the suffering of the Yemeni people caused by Saudi actions."

Brett Wilkins ·


200+ Groups to Democrats in Congress: No Holiday Recess Until You Pass Voting Rights

"Our democracy is under attack across the country, and Senate Democrats must do whatever it takes—right now—to get these critical voting rights bills signed into law."

Jake Johnson ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo